Showing results (641-650 of 5,006) with videos related to

Sort By:
Pageof 501
American Journal of Clinical Oncology|December 4, 2004
Solitary dural extramedullary plasmacytoma with inv(9)(p13q21)Keun Seok Lee, Jung-Ae Lee, Hun Ho Song, et al.
American Journal of Clinical Oncology|February 1, 1992
Intermittent intensive combination chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (cyclic PAC chemotherapy) for ovarian cancerM Inoue, K Nakanishi, G Ueda, et al.
American Journal of Clinical Oncology|February 1, 1992
Analysis of treatment failure in acute nonlymphocytic leukemia patients over fifty years of age. A Southwest Oncology Group studyD H Ryan, K J Kopecky, D Head, et al.
American Journal of Clinical Oncology|February 1, 1992
Fotemustine and DTIC combination in patients with disseminated malignant melanomaO Merimsky, M Inbar, S Chaitchik
American Journal of Clinical Oncology|April 1, 1992
Total skin electron beam radiation therapy for mycosis fungoidesS Reddy, C M Parker, H Shidnia, et al.
American Journal of Clinical Oncology|April 1, 1992
High-dose cimetidine for the treatment of metastatic renal cell carcinoma. A Hoosier Oncology Group studyL Inhorn, S D Williams, S Nattam, et al.
American Journal of Clinical Oncology|February 8, 2006
A phase I dose finding study of cisplatin, gemcitabine, and weekly docetaxel for patients with advanced transitional cell cancerAnna Tinker, Eric Winquist, Christina Canil, et al.
American Journal of Clinical Oncology|February 8, 2006
Influence of number of CAG repeats on local control in the RTOG 86-10 protocolMay Abdel-Wahab, Brian A Berkey, Awtar Krishan, et al.
American Journal of Clinical Oncology|February 8, 2006
Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?Paul Brown, Matthew M Clark, Pamela Atherton, et al.
American Journal of Clinical Oncology|February 8, 2006
Adjuvant radiotherapy in the management of soft tissue sarcoma involving the distal extremitiesGordon S Schoenfeld, Christopher G Morris, Mark T Scarborough, et al.
Pageof 501